{{medical}}
{{chembox
| ImageFile = Asymmetric dimethylarginine.svg
| ImageFile_Ref = {{chemboximage|correct|??}}
}}
'''非對稱性二甲基精氨酸'''（[[英文|英文]]：Asymmetric dimethylarginine，簡稱ADMA）是一種自然存在於[[血漿|血漿]]內的[[化合物|化合物]]。它是在人體[[細胞|細胞]]內[[細胞質|細胞質]]中發生的[[蛋白質|蛋白質]]修飾過程產生的[[代謝|代謝]]副產物，與[[精氨酸|精氨酸]]有著密切關係。ADMA會影響精氨酸產生[[一氧化氮|一氧化氮]]的過程，一氧化氮是對[[內皮細胞|內皮細胞]]及[[循環系統|心血管]]健康的物質。

== 發現 ==
非對稱性二甲基精氨酸的介入角色首次在[[倫敦|倫敦]]被發現<ref>{{cite journal | author= Vallance P., Leone A.,  Calver A.,  Collier J., Moncada S. | year=1992 | title=Endogenous dimethyl-arginine as an inhibitor of nitric oxide synthesis | journal=J. Cardiovasc. Pharmacol | volume=20 |issue=Suppli. 12 | pages=S60-S62}}</ref>，今天生物化學及臨床研究繼而發現ADMA與[[心血管疾病|心血管疾病]]、[[糖尿病|糖尿病]]、[[陽痿|陽痿]]及其他[[腎臟|腎臟]]疾病的關係。ADMA亦在非常重要的—氧化氮路徑有著重大的影響。

== 人體內的合成及調節 ==
[[File:Heart-and-lungs.jpg|thumb]]
非對稱性二甲基精氨酸是在[[蛋白質|蛋白質]]的後轉譯修飾中，經由[[甲基化|甲基化]]所生成。這個反應是由一群稱為[[S-腺苷基蛋氨酸蛋白質N-甲基轉移酶|S-腺苷基蛋氨酸蛋白質N-甲基轉移酶]]（蛋白質甲基酶I及II）所催化。<ref>{{cite journal | author=Rawal N, Rajpurohit R, Lischwe MA, Williams KR, Paik WK, Kim S | title=Structural specificity of substrate for S-adenosylmethionine:protein arginine N-methyltransferases | journal=Biochim Biophys Acta | year=1995 | pages=11-8 | volume=1248 | issue=1 | id=PMID 7536038}} </ref>組成ADMA的[[甲基|甲基]]，是由代謝[[高半胱氨酸|高半胱氨酸]]的中間物：[[S-腺苷基蛋氨酸|S-腺苷基蛋氨酸]]所釋出（高半胱氨酸是一種重要的[[血液|血液]]化合物，心血管疾病的基因標誌）。在合成後，ADMA會移向[[細胞|細胞]]外的空間，並進入[[血漿|血漿]]內。ADMA可以利用[[高效液相層析儀|高效液相層析儀]]來量度。

[[File:Kidney_section.jpg|thumb]]
ADMA的濃度會受普通或氧化後的[[低密度脂蛋白|低密度脂蛋白]][[膽固醇|膽固醇]]大量的提升。<ref>{{cite journal | author=Boger RH, Sydow K, Borlak J, Thum T, Lenzen H, Schubert B, Tsikas D, Bode-Boger SM | title=LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases | journal=Circ Res | year=2000 | pages=99-105 | volume=87 | issue=2 | id=PMID 10903992 | url=http://circres.ahajournals.org/cgi/content/full/87/2/99}}</ref>因此，高內皮低密度脂蛋白會提升ADMA值，出現了一個循環效應，並且阻礙了能令[[血管舒張|血管舒張]]的[[一氧化氮|一氧化氮]]。要減少ADMA，需要透過排泄[[尿素|尿素]]及以[[二甲基精氨酸二甲胺水解酶|二甲基精氨酸二甲胺水解酶]]（DDAH）代謝。在體內生成二甲基精氨酸二甲胺水解酶或[[多酚抗氧化劑|多酚抗氧化劑]]亦可減少高半胱氨酸的水平，減低患有心血管疾病的風險。

== 與治療學的關係 ==
由於非對稱性二甲基精氨酸的高水平會對身體有害，導致如[[心血管疾病|心血管疾病]]、[[代謝疾病|代謝疾病]]及其他老年的疾病等，所以降低ADMA水平有著重要的治療成效。但是，現時仍未能有效地控制ADMA水平及臨床的經驗。

由於脂質調節的異常情況與ADMA有所關聯，有建議攝取[[脂肪酸|游離脂肪酸]]可以控制ADMA水平。但是，研究卻未能證實此種說法。<ref name=NutrMetab2006-Eid>{{cite journal | author=Eid HM, Arnesen H, Hjerkinn EM, Lyberg T, Ellingsen I, Seljeflot I | title=Effect of diet and omega-3 fatty acid intervention on asymmetric dimethylarginine | journal=Nutr Metab (Lond) | year=2006 | pages=4 | volume=3 | id=PMID 16396682 | url =http://www.nutritionandmetabolism.com/content/3/1/4}}</ref><ref name=HormMetabRes2005-Namiranian>{{cite journal | author=Namiranian K, Mittermayer F, Artwohl M, Pleiner J, Schaller G, Mayer BX, Bayerle-Eder M, Roden M, Baumgartner-Parzer S, Wolzt M | title=Free fatty acids do not acutely increase asymmetrical dimethylarginine concentrations | journal=Horm Metab Res | year=2005 | pages=768-72 | volume=37 | issue=12 | id=PMID 16372232}}</ref>

ADMA亦與[[高半胱氨酸|高半胱氨酸]]的上升有所關聯。<ref name=Atherosclerosis2006-Krzyzanowska>{{cite journal | author=Krzyzanowska K, Mittermayer F, Krugluger W, Schnack C, Hofer M, Wolzt M, Schernthaner G | title=Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes | journal=Atherosclerosis | year=2006 | pages= | volume= | id=PMID 16414052}}</ref><ref name=VascMed2006-Dayal>{{cite journal | author=Dayal S, Lentz SR | title=ADMA and hyperhomocysteinemia | journal=Vasc Med | year=2005 | pages=S27-33 | volume=10 Suppl 1 | id=PMID 16444866}}</ref><ref name=CurrDrugMetab2005-Stuhlinger>{{cite journal | author=Stuhlinger MC, Stanger O | title=Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction | journal=Curr Drug Metab | year=2005 | pages=3-14 | volume=6 | issue=1 | id=PMID 15720202}}</ref>有猜測認為可以透過攝取[[葉酸|葉酸]]來調節高半胱氨酸的水平，但研究卻認為這未能提供任何臨床的好處及[[維他命B|維他命B]]會相反增加心血管的壓力。<ref name="JAmCollCardiol2006-Zoungas">{{cite journal | author=Zoungas S, McGrath BP, Branley P, Kerr PG, Muske C, Wolfe R, Atkins RC, Nicholls K, Fraenkel M, Hutchison BG, Walker R, McNeil JJ | title=Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial | journal=J Am Coll Cardiol | year=2006 | pages=1108-16 | volume=47 | issue=6 | id=PMID 16545638}}</ref><ref name="NEJM2006a">{{cite journal | author= | title=Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease | journal=N Engl J Med | year=2006 | pages= | volume= | id=PMID 16531613 | url=http://content.nejm.org/cgi/reprint/NEJMoa060900v1.pdf}}</ref><ref name="NEJM2006-Bonna">{{cite journal | author=Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K | title=Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction | journal=N Engl J Med | year=2006 | pages= | volume= | id=PMID 16531614 | url=http://content.nejm.org/cgi/reprint/NEJMoa055227v1.pdf}}</ref>

有建議指攝取[[精氨酸|精氨酸]]可以直接控制ADMA水平。<ref name="VascMed2003-Bode-Boger">{{cite journal | author=Bode-Boger SM, Muke J, Surdacki A, Brabant G, Boger RH, Frolich JC | title=Oral L-arginine improves endothelial function in healthy individuals older than 70 years | journal=Vasc Med | year=2003 | pages=77-81 | volume=8 | issue=2 | id=PMID 14518608}}</ref><ref>{{cite book | author=John P. Cooke | title=The Cardiovascular Cure | publisher=Random House | year=2002 | id=ISBN 978-0-7679-0881-8}}</ref>這不單能促進內皮的功能，且能減少心血管疾病的臨床病徵。<ref>{{cite journal | author=Rector TS, Bank AJ, Mullen KA, Tschumperlin LK, Sih R, Pillai K, Kubo SH | title=Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure | journal=Circulation | year=1996 | pages=2135-41 | volume=93 | issue=12 | id=PMID 8925582 | url=http://circ.ahajournals.org/cgi/content/full/93/12/2135}}</ref><ref>{{cite journal | author=Ceremuzynski L, Chamiec T, Herbaczynska-Cedro K | title=Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris | journal=Am J Cardiol | year=1997 | pages=331-3 | volume=80 | issue=3 | id=PMID 9264427}}</ref>但是，有些研究在臨床的結果上有著差異<ref name="JNutr2004-Loscalzo">{{cite journal | author=Loscalzo J | title=L-arginine and atherothrombosis | journal=J Nutr | year=2004 | pages=2798S-2800S; discussion 2818S-2819S | volume=134 | issue=10 Suppl | id=PMID 15465788 | url=http://www.nutrition.org/cgi/content/full/134/10/2798S | deadurl=yes | archiveurl=https://web.archive.org/web/20041210013955/http://www.nutrition.org/cgi/content/full/134/10/2798S | archivedate=2004-12-10 }}</ref>及在控制高半胱氨酸時須加倍留意病人的狀況。

[[他汀|他汀]]除了能影響血液內的[[膽固醇|膽固醇]]水平外，亦能增加[[一氧化氮|一氧化氮]]及對[[心臟|心臟]]供血的直接影響。ADMA的上升會影響他汀的效用及病人對他汀的反應。<ref name="VascMed2003-Janatuinen">{{cite journal | author=Janatuinen T, Laakso J, Laaksonen R, Vesalainen R, Nuutila P, Lehtimaki T, Raitakari OT, Knuuti J | title=Plasma asymmetric dimethylarginine modifies the effect of pravastatin on myocardial blood flow in young adults | journal=Vasc Med | year=2003 | pages=185-9 | volume=8 | issue=3 | id=PMID 14989559}}</ref>

== 內部連結 ==
* [[精氨酸|精氨酸]]
* [[心血管疾病|心血管疾病]]
* [[高血壓|高血壓]]
* [[一氧化氮|一氧化氮]]
* [[他汀|他汀]]
* [[血管收縮|血管收縮]]

== 參考 ==
<div class="references-small">
<references />
</div>

== 外部連結==
*[http://www.medicalnewstoday.com/medicalnews.php?newsid=31545 Medical News Today於2006年3月27日有關ADMA的文章]
*[https://web.archive.org/web/20100608172434/http://www.allaboutadma.com/ ADMA研究文章概覽]
*[http://www.adma.com www.adma.com]

[[分類:α-胺基酸|分類:α-胺基酸]]
[[分類:胍|分類:胍]]